North News
New Delhi, December 18
India’s pharmaceutical market for the fiscal year 2023-24 is valued at USD 50 billion, with domestic consumption at USD 23.5 billion and exports at USD 26.5 billion. The Indian pharmaceutical industry is the third-largest in the world by volume and ranks 14th in terms of production value.
The market spans a diverse range of products, including generic drugs, bulk drugs, vaccines, biosimilars, and biologics, making it a key player in the global pharmaceutical sector. According to National Accounts Statistics 2024, the output for pharmaceuticals in FY 2022-23 was INR 4,56,246 crores, with a value-added output of INR 1,75,583 crores. This information was provided by Union Minister of State for Chemicals and Fertilizers, Anupriya Patel, in a written response to a question in the Rajya Sabha.
The sector employed over 925,000 people in FY 2022-23. India’s pharmaceutical research and development (R&D) ecosystem is bolstered by institutions like the National Institutes of Pharmaceutical Education and Research (NIPERs), which focus on high-end research and innovation in pharmaceutical science.
The Department of Pharmaceuticals has also launched a National Policy on R&D and Innovation in the Pharma-MedTech sector to promote drug discovery and medical device innovation, supporting India’s goal to lead in pharmaceutical and medical technology advancements.
Chandigarh, June 26 Retired Deputy Inspector General (DIG) of Punjab Police, Inderjit Singh Sidhu, on…
Dehradun, June 26 A tense standoff between Nihang Sikhs and police at the Himachal Pradesh…
Jabalpur, June 26 The Madhya Pradesh High Court on Thursday dismissed a defamation case against…
Chandigarh, June 25 The National Council of Educational Research and Training (NCERT) has added a…
